These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19713535)

  • 1. Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells.
    Sanada F; Taniyama Y; Iekushi K; Azuma J; Okayama K; Kusunoki H; Koibuchi N; Doi T; Aizawa Y; Morishita R
    Circ Res; 2009 Sep; 105(7):667-75, 13 p following 675. PubMed ID: 19713535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor inhibits lipopolysaccharide-induced oxidative stress via epithelial growth factor receptor degradation.
    Shimizu K; Taniyama Y; Sanada F; Azuma J; Iwabayashi M; Iekushi K; Rakugi H; Morishita R
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2687-93. PubMed ID: 22936342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
    Ashino T; Yamamoto M; Yoshida T; Numazawa S
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling.
    Dai F; Qi Y; Guan W; Meng G; Liu Z; Zhang T; Yao W
    Atherosclerosis; 2019 Sep; 288():124-136. PubMed ID: 31362179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.
    Ushio-Fukai M; Zuo L; Ikeda S; Tojo T; Patrushev NA; Alexander RW
    Circ Res; 2005 Oct; 97(8):829-36. PubMed ID: 16151024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of smooth muscle 22α facilitates angiotensin II-induced ROS production via activation of the PKCδ-P47phox axis through release of PKCδ and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in vitro and in vivo.
    Lv P; Miao SB; Shu YN; Dong LH; Liu G; Xie XL; Gao M; Wang YC; Yin YJ; Wang XJ; Han M
    Circ Res; 2012 Aug; 111(6):697-707. PubMed ID: 22798525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HGF/c-Met signalling promotes Notch3 activation and human vascular smooth muscle cell osteogenic differentiation in vitro.
    Liu Y; Wang T; Yan J; Jiagbogu N; Heideman DA; Canfield AE; Alexander MY
    Atherosclerosis; 2011 Dec; 219(2):440-7. PubMed ID: 21920521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway.
    Bihl JC; Zhang C; Zhao Y; Xiao X; Ma X; Chen Y; Chen S; Zhao B; Chen Y
    Vascul Pharmacol; 2015 Oct; 73():115-123. PubMed ID: 26264508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.
    Iekushi K; Taniyama Y; Kusunoki H; Azuma J; Sanada F; Okayama K; Koibuchi N; Iwabayashi M; Rakugi H; Morishita R
    Hypertension; 2011 Aug; 58(2):190-6. PubMed ID: 21670418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
    Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
    Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.
    Zhang F; Li S; Song J; Liu J; Cui Y; Chen H
    Atherosclerosis; 2017 Jun; 261():90-98. PubMed ID: 28283184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
    Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
    Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II promotes the inflammatory response to CD40 ligation via TRAF-2.
    Ruef J; Browatzki M; Pfeiffer CA; Schmidt J; Kranzhöfer R
    Vasc Med; 2007 Feb; 12(1):23-7. PubMed ID: 17451090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II.
    Ohtsu H; Dempsey PJ; Frank GD; Brailoiu E; Higuchi S; Suzuki H; Nakashima H; Eguchi K; Eguchi S
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):e133-7. PubMed ID: 16840716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
    Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peach (Prunus persica) extract inhibits angiotensin II-induced signal transduction in vascular smooth muscle cells.
    Kono R; Okuno Y; Nakamura M; Inada K; Tokuda A; Yamashita M; Hidaka R; Utsunomiya H
    Food Chem; 2013 Aug; 139(1-4):371-6. PubMed ID: 23561119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubules regulate angiotensin II type 1 receptor and Rac1 localization in caveolae/lipid rafts: role in redox signaling.
    Zuo L; Ushio-Fukai M; Hilenski LL; Alexander RW
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1223-8. PubMed ID: 15142861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.